<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01629134</url>
  </required_header>
  <id_info>
    <org_study_id>MAF/AGN/MED/FIL/019</org_study_id>
    <nct_id>NCT01629134</nct_id>
  </id_info>
  <brief_title>Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergan Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allergan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, multicenter postmarket study of the use of JUVÉDERM VOLBELLA™ with Lidocaine
      in the lips.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Subject Rating of the Natural Look and Feel of the Lips</measure>
    <time_frame>4 weeks</time_frame>
    <description>Percentage of subjects rating the look and feel of their lips as being extremely natural, very natural, slightly natural, and not natural.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Injector Rating of the Natural Look and Feel of the Lips</measure>
    <time_frame>4 weeks</time_frame>
    <description>Percentage of injectors who rated the look and feel of subjects' lips as being extremely natural, very natural, slightly natural, and not natural.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bruising of the Lips</measure>
    <time_frame>15 minutes after injection</time_frame>
    <description>Injector assessment of whether there was none, little, some, moderate, or considerable bruising in subjects' lips</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swelling of the Lips</measure>
    <time_frame>15 minutes after injection</time_frame>
    <description>Injector assessment of whether there was none, little, some, moderate, or considerable swelling in subjects' lips</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of Injection</measure>
    <time_frame>15 minutes after injection</time_frame>
    <description>Injectors rated the ease of injection on a scale ranging from 0 (Very easy) to 10 (Extremely difficult)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Malleability of Product</measure>
    <time_frame>15 minutes after injection</time_frame>
    <description>Injectors rated the malleability on a scale ranging from 0 (Extremely malleable/Not hard to mold) to 10 (Not malleable/Hard to mold)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for Massage</measure>
    <time_frame>15 minutes after injection</time_frame>
    <description>Injectors rated whether none/minimal, a little, some, or a lot of massage was required to optimize placement of VOLBELLA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to Social Engagement</measure>
    <time_frame>4 weeks</time_frame>
    <description>Time to return to normal daily activities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparative Rating With Previous Treatment</measure>
    <time_frame>15 minutes after injection</time_frame>
    <description>Subject rating of lip improvement with VOLBELLA compared with previous lip enhancement treatments as significantly better, somewhat better, no difference, somewhat worse, or significantly worse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rating of Injection Discomfort</measure>
    <time_frame>15 minutes after injection</time_frame>
    <description>The level of discomfort during treatment on a scale of 0 (no discomfort) to 10 (extreme discomfort).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">62</enrollment>
  <condition>Lip Augmentation</condition>
  <arm_group>
    <arm_group_label>Volbella</arm_group_label>
    <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Crosslinked hyaluronic acid gel</intervention_name>
    <description>All treatments are carried out according to the physician's experience and the Directions for Use</description>
    <arm_group_label>Volbella</arm_group_label>
    <other_name>JUVÉDERM VOLBELLA™</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers desiring lip augmentation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Desire and willingness for correction of asymmetry or volume enhancement of his/her
             lips

          -  Females and males ≥ 18 years of age

          -  Have established a realistic treatment goal that the Physician agrees is achievable,
             i.e., have realistic expectations of aesthetic results

        Exclusion Criteria:

          -  Not fulfilling the standard prescribing criteria for JUVÉDERM VOLBELLA™ with Lidocaine
             as detailed in the Directions for Use

          -  Have a condition or be in a situation that, in the Physician's opinion, may put the
             subject at significant risk, may confound the study results, or may interfere
             significantly with the subject's participation in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Allergan Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Dusseldorf</city>
        <state>North Rhine-Westphalia</state>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Philipp-Dormston WG, Hilton S, Nathan M. A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips. J Cosmet Dermatol. 2014 Jun;13(2):125-34. doi: 10.1111/jocd.12085.</citation>
    <PMID>24910276</PMID>
  </results_reference>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2012</study_first_submitted>
  <study_first_submitted_qc>June 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2012</study_first_posted>
  <results_first_submitted>March 21, 2013</results_first_submitted>
  <results_first_submitted_qc>March 21, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 14, 2013</results_first_posted>
  <last_update_submitted>October 3, 2014</last_update_submitted>
  <last_update_submitted_qc>October 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Volbella</title>
          <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Volbella</title>
          <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="62"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.7" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Subject Rating of the Natural Look and Feel of the Lips</title>
        <description>Percentage of subjects rating the look and feel of their lips as being extremely natural, very natural, slightly natural, and not natural.</description>
        <time_frame>4 weeks</time_frame>
        <population>All subjects who met the criteria and treatment was initiated</population>
        <group_list>
          <group group_id="O1">
            <title>Volbella</title>
            <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Rating of the Natural Look and Feel of the Lips</title>
          <description>Percentage of subjects rating the look and feel of their lips as being extremely natural, very natural, slightly natural, and not natural.</description>
          <population>All subjects who met the criteria and treatment was initiated</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Extremely natural</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Very natural</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slightly natural</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not natural</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Injector Rating of the Natural Look and Feel of the Lips</title>
        <description>Percentage of injectors who rated the look and feel of subjects’ lips as being extremely natural, very natural, slightly natural, and not natural.</description>
        <time_frame>4 weeks</time_frame>
        <population>All subjects who met the criteria and treatment was initiated</population>
        <group_list>
          <group group_id="O1">
            <title>Volbella</title>
            <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
          </group>
        </group_list>
        <measure>
          <title>Injector Rating of the Natural Look and Feel of the Lips</title>
          <description>Percentage of injectors who rated the look and feel of subjects’ lips as being extremely natural, very natural, slightly natural, and not natural.</description>
          <population>All subjects who met the criteria and treatment was initiated</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Extremely natural</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Very natural</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slightly natural</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not natural</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bruising of the Lips</title>
        <description>Injector assessment of whether there was none, little, some, moderate, or considerable bruising in subjects’ lips</description>
        <time_frame>15 minutes after injection</time_frame>
        <population>All subjects who met the criteria and treatment was initiated</population>
        <group_list>
          <group group_id="O1">
            <title>Volbella</title>
            <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
          </group>
        </group_list>
        <measure>
          <title>Bruising of the Lips</title>
          <description>Injector assessment of whether there was none, little, some, moderate, or considerable bruising in subjects’ lips</description>
          <population>All subjects who met the criteria and treatment was initiated</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Little</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Some</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Considerable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Swelling of the Lips</title>
        <description>Injector assessment of whether there was none, little, some, moderate, or considerable swelling in subjects’ lips</description>
        <time_frame>15 minutes after injection</time_frame>
        <population>All subjects who met the criteria and treatment was initiated</population>
        <group_list>
          <group group_id="O1">
            <title>Volbella</title>
            <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
          </group>
        </group_list>
        <measure>
          <title>Swelling of the Lips</title>
          <description>Injector assessment of whether there was none, little, some, moderate, or considerable swelling in subjects’ lips</description>
          <population>All subjects who met the criteria and treatment was initiated</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Little</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Some</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Considerable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ease of Injection</title>
        <description>Injectors rated the ease of injection on a scale ranging from 0 (Very easy) to 10 (Extremely difficult)</description>
        <time_frame>15 minutes after injection</time_frame>
        <population>All subjects who met the criteria and treatment was initiated</population>
        <group_list>
          <group group_id="O1">
            <title>Volbella</title>
            <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
          </group>
        </group_list>
        <measure>
          <title>Ease of Injection</title>
          <description>Injectors rated the ease of injection on a scale ranging from 0 (Very easy) to 10 (Extremely difficult)</description>
          <population>All subjects who met the criteria and treatment was initiated</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Score of 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Score of 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Malleability of Product</title>
        <description>Injectors rated the malleability on a scale ranging from 0 (Extremely malleable/Not hard to mold) to 10 (Not malleable/Hard to mold)</description>
        <time_frame>15 minutes after injection</time_frame>
        <population>All subjects who met the criteria and treatment was initiated</population>
        <group_list>
          <group group_id="O1">
            <title>Volbella</title>
            <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
          </group>
        </group_list>
        <measure>
          <title>Malleability of Product</title>
          <description>Injectors rated the malleability on a scale ranging from 0 (Extremely malleable/Not hard to mold) to 10 (Not malleable/Hard to mold)</description>
          <population>All subjects who met the criteria and treatment was initiated</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Score of 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Score of 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Need for Massage</title>
        <description>Injectors rated whether none/minimal, a little, some, or a lot of massage was required to optimize placement of VOLBELLA</description>
        <time_frame>15 minutes after injection</time_frame>
        <population>All subjects who met the criteria and treatment was initiated</population>
        <group_list>
          <group group_id="O1">
            <title>Volbella</title>
            <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
          </group>
        </group_list>
        <measure>
          <title>Need for Massage</title>
          <description>Injectors rated whether none/minimal, a little, some, or a lot of massage was required to optimize placement of VOLBELLA</description>
          <population>All subjects who met the criteria and treatment was initiated</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>None/minimal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A little</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Some</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A lot</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Return to Social Engagement</title>
        <description>Time to return to normal daily activities</description>
        <time_frame>4 weeks</time_frame>
        <population>All subjects who met the criteria and treatment was initiated</population>
        <group_list>
          <group group_id="O1">
            <title>Volbella</title>
            <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
          </group>
        </group_list>
        <measure>
          <title>Return to Social Engagement</title>
          <description>Time to return to normal daily activities</description>
          <population>All subjects who met the criteria and treatment was initiated</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>&lt; 1 Day (same day)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Day (next day)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2-3 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4-5 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 6 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparative Rating With Previous Treatment</title>
        <description>Subject rating of lip improvement with VOLBELLA compared with previous lip enhancement treatments as significantly better, somewhat better, no difference, somewhat worse, or significantly worse</description>
        <time_frame>15 minutes after injection</time_frame>
        <population>All subjects who met the criteria and treatment was initiated</population>
        <group_list>
          <group group_id="O1">
            <title>Volbella</title>
            <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
          </group>
        </group_list>
        <measure>
          <title>Comparative Rating With Previous Treatment</title>
          <description>Subject rating of lip improvement with VOLBELLA compared with previous lip enhancement treatments as significantly better, somewhat better, no difference, somewhat worse, or significantly worse</description>
          <population>All subjects who met the criteria and treatment was initiated</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Significantly better</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Somewhat better</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No difference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Somewhat worse</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Significantly worse</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rating of Injection Discomfort</title>
        <description>The level of discomfort during treatment on a scale of 0 (no discomfort) to 10 (extreme discomfort).</description>
        <time_frame>15 minutes after injection</time_frame>
        <population>All subjects who met the criteria and treatment was initiated</population>
        <group_list>
          <group group_id="O1">
            <title>Volbella</title>
            <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
          </group>
        </group_list>
        <measure>
          <title>Rating of Injection Discomfort</title>
          <description>The level of discomfort during treatment on a scale of 0 (no discomfort) to 10 (extreme discomfort).</description>
          <population>All subjects who met the criteria and treatment was initiated</population>
          <units>scale score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Volbella</title>
          <description>Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use
Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Medical Monitor</name_or_title>
      <organization>Allergan, Inc.</organization>
      <phone>714-246-4500</phone>
      <email>clinicaltrials@allergan.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

